Gareth Brady
- Immunology top 2%
- interferon and immune responses 10
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Cancer Research top 5%
- NF-κB Signaling Pathways 6
- Virology top 5%
- Poxvirus research and outbreaks 5
- Microbiology top 5%
- Oncology top 10%
- Viral-associated cancers and disorders 4
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 4
-
- Herpesvirus Infections and Treatments 6
- Co-authors
- Andrew BowiePaul J. FarrellLuke O'neillCaroline A. JefferiesKatherine A. FitzgeraldAisling DunneGeorgina J MacArthurElizabeth Brint
- Cited by
- ImmunologyCancer ResearchVirology
- Journals
- Journal of Virology (5 papers)Biochemical Pharmacology (3 papers)Frontiers in Immunology (2 papers)
- Partner nations
- IrelandUnited KingdomGermany
In The Last Decade
Gareth Brady
30 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Immunology 1.2k
- Cancer Research 373
- Virology 111
- Microbiology 100
- Oncology 359
Countries citing papers authored by Gareth Brady
This map shows the geographic impact of Gareth Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gareth Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gareth Brady more than expected).
Fields of papers citing papers by Gareth Brady
This network shows the impact of papers produced by Gareth Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gareth Brady. The network helps show where Gareth Brady may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gareth Brady, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 33 | |
| 10 | 2022 | 31 | |
| 11 | 2021 | 11 | |
| 12 | 2020 | 11 | |
| 13 | 2020 | 32 | |
| 14 | 2019 | 50 | |
| 15 | 2018 | 3 | |
| 16 | 2009 | 16 | |
| 17 | 2009 | 38 | |
| 18 | 2008 | 54 | |
| 19 | 2005 | 64 | |
| 20 | Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transductionbreakdown → | 2001 | 1006 |
About Gareth Brady
Gareth Brady is a scholar working on Virology, Immunology and Modeling and Simulation, having authored 32 papers that have together received 1.9k indexed citations. Recurring topics across this work include interferon and immune responses (10 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Herpesvirus Infections and Treatments (6 papers), NF-κB Signaling Pathways (6 papers), Poxvirus research and outbreaks (5 papers), COVID-19 Clinical Research Studies (4 papers), Viral-associated cancers and disorders (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). The work is most often cited by research in Immunology (1.2k citations), Cancer Research (373 citations) and Virology (111 citations). Gareth Brady has collaborated with scholars based in Ireland, United Kingdom and Germany. Frequent co-authors include Andrew Bowie, Paul J. Farrell, Luke O'neill, Caroline A. Jefferies, Katherine A. Fitzgerald, Aisling Dunne, Georgina J MacArthur, Elizabeth Brint, Pearl Gray and Ashley Mansell. Their work appears in journals such as Journal of Virology, Biochemical Pharmacology, Frontiers in Immunology, Journal of General Virology and Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.